FDA
-
-
-
-
-
-
-
United Therapeutics receives FDA regenerative medicine designation for liver device
-
-
-
-
-
-
-
United Therapeutics ralinepag shows 55% risk reduction in PAH study
-
-
-
-
-
-
-
TD Cowen on Biotechnology: '10+ Potential "Thome Run" Catalysts To Watch In 2026'
-
-
-
-
-
-
-
United Therapeutics Corporation Reports Record Second Quarter 2025 Financial Results
-
-
-
-
-
-
-
United Therapeutics Corporation Announces FDA Clearance of its Investigational New Drug Application for the UKidney Xenotransplantation Clinical Trial
-
-
-
-
-
-
-
United Therapeutics Corp. (UTHR) PT Raised to $380 at Wells Fargo
-
-
-
-
-
-
-
United Therapeutics Announces the First Comprehensive Review Publication on Xenotransplantation
-
322,897 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

